DISCOUNT-OPTIONSSCHEIN - AMGEN | Market Closed - BOERSE MUENCHEN 20:45:36 31/05/2024 BST | ||
| 2.3 EUR | +0.44% |
|
| 3 months | +41.98% | ||
| 6 months | +61.97% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 31/05/24 | 2.3 | +0.44% |
| 30/05/24 | 2.29 | +0.44% |
| 29/05/24 | 2.28 | -.--% |
| 28/05/24 | 2.28 | -.--% |
| 27/05/24 | 2.28 | -0.87% |
Real-time BOERSE MUENCHEN
Last update May 31, 2024 at 08:45 pm
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HC3BW8 |
| ISIN | DE000HC3BW87 |
| Date issued | 23/01/2023 |
| Strike | 250 $ |
| Maturity | 19/06/2024 (17 Days) |
| Parity | 10 : 1 |
| Emission price | 1.24 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.3 € |
|---|---|
| Lowest since issue | 0.52 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305.8
USD
Average target price
316.3
USD
Spread / Average Target
+3.41%
- Stock Market
- Certificates
- Certificat
